Logo image of ALBPK.PA

BROADPEAK (ALBPK.PA) Stock Fundamental Analysis

EPA:ALBPK - Euronext Paris - Matif - FR001400AJZ7 - Common Stock - Currency: EUR

1.605  -0.02 (-1.23%)

Fundamental Rating

2

Taking everything into account, ALBPK scores 2 out of 10 in our fundamental rating. ALBPK was compared to 26 industry peers in the Communications Equipment industry. ALBPK has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALBPK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALBPK had negative earnings in the past year.
ALBPK had a positive operating cash flow in the past year.
In multiple years ALBPK reported negative net income over the last 5 years.
In multiple years ALBPK reported negative operating cash flow during the last 5 years.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ALBPK's Return On Assets of -7.91% is in line compared to the rest of the industry. ALBPK outperforms 42.31% of its industry peers.
ALBPK has a Return On Equity of -19.96%. This is in the lower half of the industry: ALBPK underperforms 61.54% of its industry peers.
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

ALBPK has a better Gross Margin (100.47%) than 100.00% of its industry peers.
ALBPK's Gross Margin has improved in the last couple of years.
ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

More info and screens

3

2. Health

2.1 Basic Checks

ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBPK has about the same amount of shares outstanding.
Compared to 1 year ago, ALBPK has an improved debt to assets ratio.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALBPK has an Altman-Z score of 0.78. This is a bad value and indicates that ALBPK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.78, ALBPK is doing worse than 65.38% of the companies in the same industry.
ALBPK has a debt to FCF ratio of 16.11. This is a negative value and a sign of low solvency as ALBPK would need 16.11 years to pay back of all of its debts.
The Debt to FCF ratio of ALBPK (16.11) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.44 indicates that ALBPK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.44, ALBPK is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Altman-Z 0.78
ROIC/WACCN/A
WACC6.37%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALBPK has a Current Ratio of 1.29. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
ALBPK's Current ratio of 1.29 is on the low side compared to the rest of the industry. ALBPK is outperformed by 69.23% of its industry peers.
ALBPK has a Quick Ratio of 1.29. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
ALBPK has a Quick ratio (1.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

ALBPK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.09%.
ALBPK shows a small growth in Revenue. In the last year, the Revenue has grown by 0.87%.
The Revenue has been growing slightly by 5.93% on average over the past years.
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%

3.2 Future

Based on estimates for the next years, ALBPK will show a very strong growth in Earnings Per Share. The EPS will grow by 53.57% on average per year.
Based on estimates for the next years, ALBPK will show a quite strong growth in Revenue. The Revenue will grow by 8.98% on average per year.
EPS Next Y92.45%
EPS Next 2Y53.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.77%
Revenue Next 2Y8.81%
Revenue Next 3Y8.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALBPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALBPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALBPK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29.55
EV/EBITDA N/A
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALBPK's earnings are expected to grow with 53.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.57%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBPK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROADPEAK

EPA:ALBPK (8/5/2025, 7:00:00 PM)

1.605

-0.02 (-1.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.15%
Inst Owner ChangeN/A
Ins Owners49.73%
Ins Owner ChangeN/A
Market Cap20.13M
Analysts86
Price Target2.55 (58.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.65%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF 29.55
P/OCF 1.97
P/B 1
P/tB 7.52
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.05
FCFY3.38%
OCF(TTM)0.81
OCFY50.68%
SpS3.14
BVpS1.61
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100.48%
FCFM 1.73%
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Debt/EBITDA N/A
Cap/Depr 175.48%
Cap/Sales 24.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 0.78
F-Score6
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)283.73%
Cap/Depr(5y)362.99%
Cap/Sales(3y)24.24%
Cap/Sales(5y)18.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y92.45%
EPS Next 2Y53.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%
Revenue Next Year9.77%
Revenue Next 2Y8.81%
Revenue Next 3Y8.98%
Revenue Next 5YN/A
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year164.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y371.81%
OCF growth 3Y167.99%
OCF growth 5YN/A